A new study suggests that a molecule called miR-21 is important in the development of lung cancer in never-smokers and in smokers. Lung tumors from never-smokers with mutations in a gene called EGFR had particularly high levels of the molecule. The findings may lead to improve targeted therapy for lung cancer, including tumors resistant to targeted drugs such as gefitinib.
Full article >>
Tuesday, July 28, 2009
Molecule Plays Early Role In Nonsmoking Lung Cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment